It was determined that event reporting should be included as part of Quality Assurance (QA) efforts in transfusion medicine for two main reasons.
QA is already required by regulation and a duplicate system would be resisted.
The MERS-TM system should be compatible with established QA standards of blood bank organizations such as the AABB and Federal regulations from the FDA.
